Buzz Stocks: Apple Inc., Intuitive Surgical, Inc., and Biogen Inc

Today's stocks to watch in the news include Apple Inc. (AAPL), Intuitive Surgical, Inc. (ISRG), and Biogen Inc (BIIB)

Jul 22, 2015 at 9:37 AM
facebook X logo linkedin


U.S. stocks are taking it on the chin, amid the latest round of lackluster earnings. In company news, today's stocks to watch include tech heavyweight Apple Inc. (NASDAQ:AAPL), medical equipment maker Intuitive Surgical, Inc. (NASDAQ:ISRG), and biopharmaceutical specialist Biogen Inc (NASDAQ:BIIB)

  • AAPL is staring at a nearly 7% deficit at $121.74, following last night's mixed turn in the earnings confessional. While the company posted better-than-expected fiscal third-quarter profits and sales, it also offered up a disappointing revenue forecast. Apple Inc.'s pullback is being exacerbated by an unwinding of optimism across the Street. This morning, in fact, Cowen and Company downgraded its rating to "market perform" from "outperform," while slashing its price target to $130 from $140. FBR and BofA-Merrill Lynch followed suit, reducing their price targets to $175 and $142, respectively. Additional negative notes could be forthcoming, with 22 of 34 analysts rating AAPL a "buy" or better, and its average 12-month price target of $149.28 sitting in record-high territory.

  • ISRG is basking in positive brokerage attention, following an earnings beat and expectations for surgical procedures to grow up to 13% this year. Specifically, Canaccord Genuity upgraded its opinion to "buy," and boosted its price target to $615 from $517 -- with no fewer than eight other brokerages also upping their targets. Out of the gate, Intuitive Surgical, Inc. jumped to an annual high of $564.86, and was last seen 10.3% higher at $556.89 -- putting it back into positive territory in 2015. There's plenty of sideline cash available to fuel more upside for the shares, too. ISRG's short interest ratio of 5.00 indicates it would take one week to repurchase all of its shorted shares, at typical daily trading volumes.

  • Finally, BIIB said its experimental Alzheimer's drug, aducanumab, failed to slow mental decline during a Phase I trial -- proving at least one brokerage firm right. The disappointing news has the shares sitting 4.4% lower at $391.59, and testing support at their 160-day moving average. Option traders weren't expecting this from Biogen Inc. During the last 10 days at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), speculators have bought to open 1.74 calls for every put -- a ratio that ranks in the bullishly skewed 87th percentile of its annual range.

Want an even earlier advantage on the biggest news before the bell? Sign up now to get Schaeffer's Opening View delivered straight to your inbox!

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI